NR2E3 and cervical cancer: In a phase II trial also including four PVC patients, the combination therapy of triapine, an RNR inhibitor, and cisplatin-radiotherapy, led in two patients to a survival benefit compared to cisplatin-radiotherapy only in the two other patients, also implicating a similar biological behavior of PVCs and cervical cancer [8].